John O'Brien Joins Panel Session on Drug Pricing Policy at BioNJ's 12th Annual BioPartnering Conference

  • May 11, 2022 - 9:30am - 10:15am

Join NPC and John O'Brien at BioNJ’s 12th Annual BioPartnering Conference and hear an expert panel discuss drug pricing policy proposals and the dangers for funding, innovation and patient access.

 

BioNJ12th

Join us at BioNJ's 12th Annual BioPartnering Conference, "The Future of Partnering: Evolving Opportunity Despite Uncertainty," May 9 - May 13, 2022.

On Wednesday, May 11 from 9:30 a.m. - 10:15 a.m. ET, NPC's president and CEO John M. O'Brien will join an expert panel: Drug Pricing Policy Proposals and the Dangers for Funding, Innovation and Patient Access. See more below.

 

About the Conference:

You'll enjoy interactive plenary sessions, 1:1 partnering, Company and Pitch presentations, networking and more! Presenting companies range from early start-ups to later-stage companies and everything in between. BioNJ’s BioPartnering Conference is designed to foster productive partnerships, create fruitful opportunities, grow the ecosystem and bolster medical innovation! There is a place for all company stages.

  • In-Person Networking Reception, Monday, May 9, 2022, 4:00 p.m. - 7:00 p.m. ET, The Liberty House, Jersey City, NJ
  • Virtual Conference: Tuesday, May 10 & Wednesday, May 11, 2022
  • Virtual 1:1 Partnering: Monday, May 9 through Friday, May 13, 2022

Registration Information:

Click here to learn more about the Conference. 

Featured Session: Drug Pricing Policy Proposals and the Dangers for Funding, Innovation and Patient Access | Wednesday, May 11| 9:30 a.m. - 10:15 a.m. ET

Patients are paying too much for health care. As a result, health care affordability is on the lips of policymakers everywhere. As policies are developed to address this reality, it is important to protect innovation and patient access. Economic and other experts will discuss the potentially devastating consequences of certain policy proposals on innovation and access and the need to consider the role of the entire healthcare continuum on cost.

Panelists:

  • Gary Branning, MBA, Professor, Pharmaceutical Management, Rutgers Business School & President, Managed Market Resources, LLC
  • Richard Evans, Ph.D. MPPM, General Manager, SSR Health LLC
  • John M. O’Brien, PharmD, MPH, President & CEO, National Pharmaceutical Council
  • Duane Schulthess, CEO, Vital Transformation LLC

Moderator:

  • Michele M. Oshman, Vice President, External Affairs, Executive Director, Council of State Bioscience Associations, Biotechnology Innovation Organization (BIO)
BioNJ

REGISTER NOW!